PLUME: A single-arm phase II trial evaluating the combination of pembrolizumab and lenvatinib in metastatic uveal melanoma (mUM) patients (pts) previously treated or not with tebentafusp

被引：0
|
作者：
Rodrigues, Manuel
Saint-Ghislain, Mathilde
Ramtohul, Toulsie
de Koning, Leanne
Bouchez, Clementine
Lafite, Elsa
Ajgal, Zahra Castel
Marret, Gregoire
Sanchez, Raphael
Mariani, Pascale
Nespoulous, Sandra
Gillon, Veronique
Servois, Vincent
Piperno-Neumann, Sophie
机构：
[1] Inst Curie, Med Oncol Dept, Paris, France
[2] Curie Inst, Paris, France
[3] Paris Saclay Univ, Inst Curie, Dept Drug Dev & Innovat, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9613
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long-term survivors on tebentafusp in phase II trial of previously treated patients with metastatic uveal melanoma
    Sato, T.
    Ikeguchi, A. P.
    Nathan, P.
    Carvajal, R. D.
    Shoushtari, A. N.
    Gajewski, T. F.
    Hassel, J. C.
    Rioth, M.
    Leyvraz, S.
    Daniels, G. A.
    Hernandez-Aya, L.
    Johnson, D. B.
    Kim, K.
    Piulats Rodriguez, J. M.
    Cowey, C. L.
    Lockwood, S.
    Collins, L.
    Karakuzu, O.
    Sacco, J. J.
    Butler, M. O.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S934 - S935
  • [2] Kinetics of radiographic response for tebentafusp (tebe) in previously treated metastatic uveal melanoma (mUM) patients (pts) achieving prolonged survival.
    Butler, Marcus O.
    Sato, Takami
    Carvajal, Richard D.
    Sacco, Joseph J.
    Abdullah, Shaad E.
    Holland, Chris
    Goodall, Howard
    Shoushtari, Alexander N.
    CANCER RESEARCH, 2021, 81 (13)
  • [3] Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
    Carvajal, Richard D.
    Butler, Marcus O.
    Shoushtari, Alexander N.
    Hassel, Jessica C.
    Ikeguchi, Alexandra
    Hernandez-Aya, Leonel
    Nathan, Paul
    Hamid, Omid
    Piulats, Josep M.
    Rioth, Matthew
    Johnson, Douglas B.
    Luke, Jason J.
    Espinosa, Enrique
    Leyvraz, Serge
    Collins, Laura
    Goodall, Howard M.
    Ranade, Koustubh
    Holland, Chris
    Abdullah, Shaad E.
    Sacco, Joseph J.
    Sato, Takami
    NATURE MEDICINE, 2022, 28 (11) : 2364 - +
  • [4] Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
    Richard D. Carvajal
    Marcus O. Butler
    Alexander N. Shoushtari
    Jessica C. Hassel
    Alexandra Ikeguchi
    Leonel Hernandez-Aya
    Paul Nathan
    Omid Hamid
    Josep M. Piulats
    Matthew Rioth
    Douglas B. Johnson
    Jason J. Luke
    Enrique Espinosa
    Serge Leyvraz
    Laura Collins
    Howard M. Goodall
    Koustubh Ranade
    Chris Holland
    Shaad E. Abdullah
    Joseph J. Sacco
    Takami Sato
    Nature Medicine, 2022, 28 : 2364 - 2373
  • [5] A phase II single-arm study of pembrolizumab plus lenvatinib in previously treated classic Kaposi sarcoma (CKS): The PULSAR trial
    Indini, A.
    Tourlaki, A.
    Barbin, F.
    Brambilla, L.
    Gambini, D.
    Berti, E.
    Grossi, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S1128 - S1128
  • [6] Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in patients (pts) with previously treated (2L+) metastatic uveal melanoma (mUM).
    Carvajal, Richard D.
    Sato, Takami
    Butler, Marcus O.
    Sacco, Joseph J.
    Shoushtari, Alexander Noor
    Hassel, Jessica Cecile
    Ikeguchi, Alexandra
    Hernandez-Aya, Leonel Fernando
    Rioth, Matthew
    Hamid, Omid
    Piulats, Josep M.
    Luke, Jason J.
    Buckner Johnson, Douglas
    Leyvraz, Serge
    Espinosa, Enrique
    Collins, Laura
    McCully, Michelle L.
    Lockwood, Sarah
    Abdullah, Shaad Essa
    Nathan, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Characterization of liver function tests (LFTs) following tebentafusp (tebe) in previously treated (2L+) metastatic uveal melanoma (mUM) patients (pts).
    Sato, Takami
    Carvajal, Richard D.
    Sacco, Joseph J.
    Shoushtari, Alexander Noor
    Hassel, Jessica Cecile
    Ikeguchi, Alexandra
    Hernandez-Aya, Leonel Fernando
    Nathan, Paul
    Rioth, Matthew
    Hamid, Omid
    Piulats, Josep M.
    Luke, Jason J.
    Johnson, Douglas Buckner
    Leyvraz, Serge
    Espinosa, Enrique
    Abdullah, Shaad Essa
    Sum, Daniel
    Lockwood, Sarah
    Mendez, Patricia
    Butler, Marcus O.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Neoadjuvant toripalimab plus axitinib in patients (pts) with resectable mucosal melanoma (MuM): Updated findings of a single-arm, phase II trial
    Cui, C-L.
    Li, Z.
    Wu, N.
    Li, M.
    Chen, X.
    Zheng, H.
    Gao, M.
    Wang, D.
    Lian, B.
    Wang, X.
    Tian, H.
    Si, L.
    Chi, Z.
    Sheng, X.
    Lai, Y.
    Sun, T.
    Zhang, Q.
    Kong, Y.
    Guo, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S908 - S908
  • [9] A phase (ph) II, multi-center study of the safety and efficacy of tebentafusp (tebe) (IMCgp100) in patients (pts) with metastatic uveal melanoma (mUM)
    Sacco, J. J.
    Carvajal, R.
    Butler, M. O.
    Shoushtari, A. N.
    Hassel, J. C.
    Ikeguchi, A.
    Hernandez-Aya, L.
    Nathan, P.
    Hamid, O.
    Piulats Rodriguez, J. M.
    Rioth, M.
    Johnson, D. B.
    Luke, J. J.
    Espinosa, E.
    Leyvraz, S.
    Goodall, H. M.
    Holland, C.
    Abdullah, S.
    Sato, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S1442 - S1443
  • [10] Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
    Pelster, Meredith S.
    Gruschkus, Stephen K.
    Bassett, Roland
    Gombos, Dan S.
    Shephard, Michael
    Posada, Liberty
    Glover, Maura S.
    Simien, Rinata
    Diab, Adi
    Hwu, Patrick
    Carter, Brett W.
    Patel, Sapna P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 599 - +
12345